Perytsyazyn | Neuleptyl drops for oral administration 4%, 30 ml

Latin name

Neuleptil



oral solution

Packing

bottle 30 ml.

Pharmacological action

Neuleptil has antipsychotic, antispasmodic, antiemetic, sedative, hypnotic effect.

Blocks dopaminergic receptors (mainly D2), adrenergic, serotonergic, m-cholinergic receptors.

Indications

acute psychotic disorders

chronic psychotic disorders such as schizophrenia

chronic non-schizophrenic delusional disorders

chronic hallucinatory psychoses (for the treatment and prevention of relapse).

Contraindications

Absolute: angle-closure glaucoma

urinary retention due to prostate diseases

Parkinson's disease

agranulocytosis, history of porphyria

concomitant therapy with levodopa

hypersensitivity to periciazine.

With caution, the drug should be used in patients with diseases of the cardiovascular system, renal and / or liver failure, in elderly patients (excessive sedation and hypotensive effects may develop).

Use during pregnancy and lactation

Pregnancy

Experimental studies in animals have not revealed teratogenic effects of the drug. A study of the teratogenic effect of periciazine in humans has not been conducted. As with other phenothiazine derivatives, the findings of various epidemiological prospective studies on the possible risk of fetal malformations are contradictory. There is no data on the effect of neuleptil administration during pregnancy on fetal brain development.

In rare cases, the following disorders were reported in newborns whose mothers received long-term treatment with large doses of Neuleptil: gastrointestinal disorders (bloating, etc.) associated with the atropine-like action of phenothiazines

extrapyramidal disorders.

Thus, the risk of teratogenicity of the drug, if any, is negligible. It is advisable to limit the duration of the drug during pregnancy.

If possible, at the end of pregnancy, it is desirable to reduce the dose of Neuleptil and antiparkinsonian drugs that correct them, which can potentiate the atropine-like effect of antipsychotics. In newborns, the state of the nervous system and the function of the gastrointestinal tract should be monitored.

Breastfeeding

Due to the lack of data on the penetration of the drug into breast milk, it is not recommended to breast-feed while taking the drug.

Composition

active substance: periciazine

excipients: sucrose, ascorbic acid, tartaric acid, glycerol (glycerin), peppermint leaf oil, ethanol 96%, caramel (E150d), purified water.

Dosage and administration

Dosage regimen varies significantly depending on the indications and age of the patient.

The average daily dose should be given in 2 or 3 doses, with an emphasis on evening hours.

In adults, the average daily dose may range from 30 mg to 100 mg. In some cases, it is permissible to increase the daily dose to 200 mg.

In children older than 3 years, the average daily dose is from 0.1 mg to 0.5 mg per kg of body weight.

Overdose

Overdose can cause severe extrapyramidal disorders and coma.

Treatment should be symptomatic and carried out in a specialized ward.

Storage conditions

Store in a dry, dark place at a temperature not exceeding 25 РC.

Expiration

5 years.

Deystvuyuschee substances

Perytsyazyn

Dosage form

Dosage form

drops for oral administration

Sanofi-Aventis, France